ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma

Galanina N, Iqbal M, Tomassetti S, Nousome D, Tin A, Gillespie CP, Youngberg H, Miller P, Malhotra M, Widden H, Rodriguez A, Liu MC, Narkhede M, William BM. ctDNA for MRD assessment is prognostic and predictive in newly diagnosed and relapsed/refractory lymphoma. Blood Neoplasia. 2026 May 26;3(3):100250. doi: 10.1016/j.bneo.2026.100250. PMID: 42603998; PMCID: PMC13476554.


Related Posts